Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$5.69 - $8.08 $23,357 - $33,168
4,105 Added 13.01%
35,655 $214,000
Q4 2023

Feb 13, 2024

SELL
$3.77 - $8.39 $478 - $1,065
-127 Reduced 0.4%
31,550 $251,000
Q3 2023

Nov 13, 2023

BUY
$5.2 - $8.77 $5,855 - $9,875
1,126 Added 3.69%
31,677 $205,000
Q2 2023

Aug 04, 2023

BUY
$5.86 - $7.93 $3,140 - $4,250
536 Added 1.79%
30,551 $183,000
Q1 2023

May 12, 2023

BUY
$5.85 - $9.84 $3,498 - $5,884
598 Added 2.03%
30,015 $185,000
Q4 2022

Feb 10, 2023

SELL
$6.88 - $9.55 $736 - $1,021
-107 Reduced 0.36%
29,417 $271,000
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $3,415 - $5,504
417 Added 1.43%
29,524 $279,000
Q2 2022

Aug 12, 2022

BUY
$7.65 - $14.24 $818 - $1,523
107 Added 0.37%
29,107 $296,000
Q1 2022

May 13, 2022

SELL
$13.02 - $20.78 $26,573 - $42,411
-2,041 Reduced 6.58%
29,000 $413,000
Q4 2021

Feb 11, 2022

SELL
$19.35 - $25.54 $17,976 - $23,726
-929 Reduced 2.91%
31,041 $641,000
Q3 2021

Nov 12, 2021

SELL
$21.65 - $39.49 $6,711 - $12,241
-310 Reduced 0.96%
31,970 $730,000
Q2 2021

Aug 13, 2021

BUY
$15.5 - $22.48 $82,165 - $119,166
5,301 Added 19.65%
32,280 $672,000
Q1 2021

May 07, 2021

BUY
$14.84 - $22.23 $1,053 - $1,578
71 Added 0.26%
26,979 $543,000
Q4 2020

Feb 12, 2021

SELL
$9.4 - $16.7 $7,266 - $12,909
-773 Reduced 2.79%
26,908 $407,000
Q3 2020

Nov 04, 2020

SELL
$10.54 - $24.96 $6,619 - $15,674
-628 Reduced 2.22%
27,681 $292,000
Q2 2020

Aug 12, 2020

BUY
$21.87 - $33.11 $171,963 - $260,343
7,863 Added 38.46%
28,309 $692,000
Q1 2020

May 04, 2020

BUY
$16.25 - $35.28 $24,001 - $52,108
1,477 Added 7.79%
20,446 $493,000
Q4 2019

Feb 05, 2020

SELL
$14.17 - $20.3 $2,267 - $3,248
-160 Reduced 0.84%
18,969 $327,000
Q3 2019

Nov 08, 2019

BUY
$14.42 - $22.2 $185,729 - $285,936
12,880 Added 206.11%
19,129 $276,000
Q2 2019

Aug 13, 2019

BUY
$16.26 - $26.42 $44,032 - $71,545
2,708 Added 76.48%
6,249 $119,000
Q1 2019

May 06, 2019

BUY
$15.97 - $22.5 $56,549 - $79,672
3,541 New
3,541 $66,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $153M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.